HNSCC Clinical Trials in Nashville, Tennessee
4 recruitingNashville, Tennessee
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Esophageal CancerGastric CancerCervical Cancer+5 more
Genentech, Inc.450 enrolled41 locationsNCT05581004
Recruiting
Phase 1
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Ovarian CancerCervical CancerEndometrial Cancer+6 more
Normunity AccelCo, Inc.150 enrolled9 locationsNCT07182149
Recruiting
Early Phase 1
Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
HNSCCSCC - Squamous Cell CarcinomaHNSCC,Larynx, Pharynx and Oral Cavity
Vanderbilt-Ingram Cancer Center18 enrolled1 locationNCT06819228
Recruiting
Not Applicable
High-Resolution PET-CT Imaging for Surgical Margin Visualization
CancerHNSCCSCC - Squamous Cell Carcinoma+2 more
Vanderbilt-Ingram Cancer Center50 enrolled1 locationNCT06915454